Latest Articles

Publication Date
All News Scientific
TV star Tayla Meath loses cancer battle - couriermail.com.au

TV star Tayla Meath loses cancer battle couriermail.com.au

Published: Sept. 11, 2026, 8:48 a.m.
Read Full Article
β-Glucuronidase at the gut-liver interface: Structural selectivity, enterohepatic reactivation, and the pharmacomicrobiomic case for precision inhibition.

β-Glucuronidase (β-G, EC 3.2.1.31) reverses phase II glucuronidation, and microbial β-G at the gut-liver interface reactivates biliary and circulating conjugates, closing enterohepatic loops for drugs, estrogens, bile acids, and bilirubin. …

Published: Sept. 9, 2026, midnight
Read Full Article
Antibody–drug conjugate Enterohepatic circulation Gut–liver axis Pharmacomicrobiomics Selective inhibition β-Glucuronidase
RFK Jr. Puts Firm Boners, Sperm Count Over Infant Mortality, Maternal Health, Cancer, Unimportant Things Like That - wonkette.com

RFK Jr. Puts Firm Boners, Sperm Count Over Infant Mortality, Maternal Health, Cancer, Unimportant Things Like That wonkette.com

Published: Sept. 8, 2026, 4:36 p.m.
Read Full Article
Doctoral student earns NIH award to investigate endometrial cancer vulnerabilities - Today@Wayne

Doctoral student earns NIH award to investigate endometrial cancer vulnerabilities Today@Wayne

Published: Sept. 8, 2026, 3:25 p.m.
Read Full Article
Doctoral student earns NIH award to investigate endometrial cancer vulnerabilities - today.wayne.edu

Doctoral student earns NIH award to investigate endometrial cancer vulnerabilities today.wayne.edu

Published: Sept. 8, 2026, 3:25 p.m.
Read Full Article
Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 - Business Wire

Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 Business Wire

Published: Sept. 8, 2026, 11:30 a.m.
Read Full Article
Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 - businesswire.com

Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 businesswire.com

Published: Sept. 8, 2026, 11:30 a.m.
Read Full Article
The hidden impacts of endocrine-disrupting chemicals on endometrial and pregnancy health.

Endocrine-disrupting chemicals (EDCs) are ubiquitous environmental contaminants that interfere with hormone signalling and are increasingly linked to adverse reproductive outcomes. This viewpoint highlights emerging evidence that EDC exposure disrupts both …

Published: Sept. 8, 2026, midnight
Read Full Article
bioaccumulation endocrine disrupting chemicals endometrium epigenetic changes long biological-half lives placenta reproductive health transgenerational effects
B7-H4–Targeted ADCs Signal a New Frontier for Platinum-Resistant Ovarian and Endometrial Cancer - OncLive

B7-H4–Targeted ADCs Signal a New Frontier for Platinum-Resistant Ovarian and Endometrial Cancer OncLive

Published: Sept. 5, 2026, 10:05 a.m.
Read Full Article
Advanced Endometrial Cancer Clinical Trial Pipeline Analysis: 25+ Key Companies Shaping the Future of Advanced Endometrial Cancer Therapeutics Space | DelveInsight - Business Upturn

Advanced Endometrial Cancer Clinical Trial Pipeline Analysis: 25+ Key Companies Shaping the Future of Advanced Endometrial Cancer Therapeutics Space | DelveInsight Business Upturn

Published: Sept. 3, 2026, 7:35 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!